Related Experiment Video
Updated: Apr 25, 2026

The Helsinki Rat Microsurgical Sidewall Aneurysm Model
Published on: October 12, 2014
Increasing occurrence of choledochal malformations in children: a single-center 37-year experience from Finland
Maria Hukkinen1, Antti Koivusalo, Harry Lindahl
1Pediatric Liver and Gut Research Group, University of Helsinki , Helsinki , Finland.
Insights
Choledochal malformations (CMs) incidence has tripled in Finland, with cystic CMs presenting earlier than fusiform types. Surgical removal of extrahepatic bile ducts with hepaticojejunostomy offers excellent outcomes for CMs.
Area of Science:
- Hepatobiliary surgery
- Pediatric surgery
- Gastroenterology
Background:
- Choledochal malformations (CMs) are rare congenital biliary tract anomalies.
- Limited data exists on CMs in European populations.
Purpose of the Study:
- To investigate the incidence, clinical presentation, and management outcomes of pediatric choledochal malformations in Finland.
- To analyze trends in CM types and diagnostic methods over time.
Main Methods:
- Retrospective review of medical records of 38 pediatric CM patients (1976-2013).
- Analysis of clinical data, imaging (ultrasound, MRCP, ERC), surgical procedures, and follow-up outcomes.
- Statistical analysis of incidence trends and patient demographics.
Main Results:
- Significant increase in CM incidence from 1:128,000 to 1:38,000 (p=0.017), with a rising proportion of fusiform CMs (p=0.007).
- Cystic CMs presented significantly earlier (0.8 years) than fusiform CMs (4.6 years) (p=0.001).
- Common presentations included abdominal pain (66%) and cholestasis (50%); 16% experienced pancreatitis. Surgical resection of extrahepatic bile ducts with Roux-en-Y hepaticojejunostomy was performed at a median age of 4.2 years, yielding excellent long-term results with no intrahepatic duct dilation or elevated bilirubin postoperatively.
Conclusions:
- CM incidence in Finland has significantly increased, exceeding previous Western estimates.
- Surgical management involving extrahepatic bile duct resection and hepaticojejunostomy provides excellent outcomes for Type I and IV CMs.
Objective:
Few reports on choledochal malformations (CMs) in European populations exist.
Materials And Methods:
The medical records of pediatric CM patients managed in our nationwide referral center for pediatric hepatobiliary surgery between 1976 and 2013 (n = 38; 71% females) were reviewed.
Results:
Over follow-up time, the relative proportion of fusiform CMs increased significantly (p = 0.007) and the estimated total incidence rose from 1:128,000 to 1:38,000 (p = 0.017). Cystic CMs (42%) presented at younger age than fusiform CMs (47%) (0.8 vs. 4.6 years, p = 0.001). Two-thirds had abdominal pain and half were cholestatic at presentation. Pancreatitis had occurred in 16%. In addition to ultrasound, 71% underwent magnetic resonance cholangiopancreatography and 39% underwent endoscopic retrograde cholangiopancreatography. Median CM dilatation was 15 (10-28) mm and a 12 (9-13) mm long common pancreaticobiliary channel was confirmed in 61%, increasingly during recent years. Intrahepatic biliary tree was dilated in 19%, whereas main ducts were dilated in 50%. Apart from two operated in the 1970s and one with choledochocele, patients underwent resection of extrahepatic bile ducts with Roux-en-Y hepaticojejunostomy at age of 4.2 (0.8-9.2) years. Postoperative bile leakage and hemorrhage required reoperations in two. At last follow-up 4.8 (1.3-13.2) years postoperatively, none had dilated intrahepatic biliary ducts or elevated plasma bilirubin (5 [3-7] µmol/l). Single cholangitis episodes had occurred in two, whereas others were asymptomatic.
Conclusion:
CM incidence has increased significantly in Finland, being currently over threefold higher than previous estimates in the Western world would suggest. Removal of the extrahepatic biliary tree with hepaticojejunostomy for type I and IV CMs yielded excellent results.
More Related Videos
09:59Transillumination-Assisted Dissection of Specific Stages of the Mouse Seminiferous Epithelial Cycle for Downstream Immunostaining Analyses
Published on: October 7, 2020
06:07Large Animal Model for Evaluating the Efficacy of the Gene Therapy in Ischemic Heart
Published on: September 2, 2021